Kedrion S.P.A.

Reporting payments is a legal requirement; large totals often reflect large product portfolios.

$62Kgeneral payments (2019-2025)
$0.00research payments (2019-2025)
15clinicians paid

General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.

General payments by year

2019 $0.00
2020 $0.00
2022 $36K
2023 $26K
2024 $0.00
2025 $0.00

General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.

Specialties it works with most

Pediatric Hematology-Oncology $50K

Clinicians with the largest reported totals

Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.

ClinicianLocationSpecialtyGeneral payments (2019-2025)
Amy Shapiro Indianapolis, IN Pediatric Hematology-Oncology $50,085.38
William Lumry Dallas, TX $12,014.08

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.